Veradigm (NASDAQ:MDRX) Trading Down 12.2% – Here’s Why

Veradigm Inc. (NASDAQ:MDRX)’s stock price fell 12.2% on Friday . The company traded as low as $4.30 and last traded at $4.30. 654 shares were traded during trading, a decline of 100% from the average session volume of 172,133 shares. The stock had previously closed at $4.90.

Wall Street Analyst Weigh In

Separately, Wall Street Zen raised shares of Veradigm to a “hold” rating in a research note on Saturday, March 7th.

Veradigm Trading Up 2.0%

The firm has a market capitalization of $602 million, a price-to-earnings ratio of 23.25 and a beta of 0.52. The stock’s 50 day moving average price is $4.59 and its two-hundred day moving average price is $4.65.

Veradigm Company Profile

Veradigm, Inc (NASDAQ: MDRX) is a healthcare technology company that provides a comprehensive suite of clinical, financial and analytical solutions to medical practices, health systems and life sciences organizations. The company’s offerings are designed to streamline electronic health record (EHR) workflows, optimize revenue cycle management and improve patient engagement through integrated software modules and cloud-based platforms.

Veradigm’s product portfolio includes EHR and practice management systems tailored to ambulatory and specialty care settings, as well as revenue cycle management services that encompass billing, coding and claims processing.